{"id":6647,"date":"2024-08-07T20:38:48","date_gmt":"2024-08-08T00:38:48","guid":{"rendered":"https:\/\/www.wmfc.ca\/?p=6647"},"modified":"2024-08-07T20:38:48","modified_gmt":"2024-08-08T00:38:48","slug":"nouvel-essai-clinique-du-wm-sur-la-cote-ouest-traitement-des-naifs-et-des-r-r","status":"publish","type":"post","link":"https:\/\/www.wmfc.ca\/fr\/2024\/08\/07\/new-wm-clinical-trial-on-the-west-coast-treatment-naive-and-r-r\/","title":{"rendered":"Nouvel essai clinique canadien : traitement de premi\u00e8re ligne ou subs\u00e9quente"},"content":{"rendered":"<p>Le nouvel essai clinique NCT05952037 (<a href=\"https:\/\/clinicaltrials.gov\/study\/NCT05952037\" target=\"_blank\" rel=\"noopener\">https:\/\/clinicaltrials.gov\/study\/NCT05952037<\/a>) utilise un nouvel inhibiteur de BCL-2 du nom de Sonrotoclax et s'adresse exclusivement aux patients atteints de la MW.  L'essai est mondial, mais le recrutement se fait dans un seul endroit au Canada, \u00e0 North Vancouver, \u00e0 la Clinique de Chimioth\u00e9rapie de l'H\u00f4pital Lions Gate.  Il comporte plusieurs volets qui se d\u00e9roulent en parall\u00e8le : l'un est destin\u00e9 aux patients n'ayant jamais re\u00e7u de traitement ; les trois autres sont destin\u00e9s aux patients en rechute\/r\u00e9fractaires, avec divers ant\u00e9c\u00e9dents de traitement.<\/p>","protected":false},"excerpt":{"rendered":"<p>NCT05952037 (https:\/\/clinicaltrials.gov\/study\/NCT05952037) utilise un nouvel inhibiteur de BCL-2, Sonrotoclax, et est strictement r\u00e9serv\u00e9 aux patients MW.  L'essai est mondial, mais le recrutement se fait dans un seul endroit au Canada, \u00e0 North Vancouver, \u00e0 la Clinique de Chimioth\u00e9rapie de l'H\u00f4pital Lions Gate.  Il comporte plusieurs volets qui se d\u00e9roulent en parall\u00e8le : l'un est destin\u00e9 aux patients n'ayant jamais re\u00e7u de traitement ; les trois autres sont destin\u00e9s aux patients en rechute\/r\u00e9fractaires, avec divers ant\u00e9c\u00e9dents de traitement.<\/p>","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_price":"","_stock":"","_tribe_ticket_header":"","_tribe_default_ticket_provider":"","_ticket_start_date":"","_ticket_end_date":"","_tribe_ticket_show_description":"","_tribe_ticket_show_not_going":false,"_tribe_ticket_use_global_stock":"","_tribe_ticket_global_stock_level":"","_global_stock_mode":"","_global_stock_cap":"","_tribe_rsvp_for_event":"","_tribe_ticket_going_count":"","_tribe_ticket_not_going_count":"","_tribe_tickets_list":"[]","_tribe_ticket_has_attendee_info_fields":false,"footnotes":""},"categories":[26],"tags":[],"class_list":["post-6647","post","type-post","status-publish","format-standard","hentry","category-physician-info"],"_links":{"self":[{"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/posts\/6647","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/comments?post=6647"}],"version-history":[{"count":3,"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/posts\/6647\/revisions"}],"predecessor-version":[{"id":6650,"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/posts\/6647\/revisions\/6650"}],"wp:attachment":[{"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/media?parent=6647"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/categories?post=6647"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.wmfc.ca\/fr\/wp-json\/wp\/v2\/tags?post=6647"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}